"Aphea.Bio submits applications for first biofungicides VALORIA™ and VIRTUOSA™ for regulatory approval to the EPA (US)."

View press releases

Challenge the conventional.
Change the norm.

Aphea.Bio is dedicated to food security and ensuring a safe and healthy food chain. We aim to provide novel science-based solutions to build the agriculture of the future: sustainable, reliable and profitable.

Aphea.Bio is proud to be a member of the B Corp community committed to using business as a force for good.

B Corp certification badge


Aphea.Bio was founded in 2017 as a spin-off of the VIB and its partner universities Ghent University and KU Leuven.


Aphea.Bio has more than 30 products in the pipeline for the next years, with the first launch in 2023.


The company can count on a solid & diverse team of more than 40 colleagues from +10 nationalities with scientific and industry experience.


Aphea.Bio has a strong management team with more than 150 years of joint relevant experience.

Aphea.Bio is a fully integrated product development company

Opening the untapped microbial space

Crops that only a few address

High-throughput and versatile R&D platform

Rich pipeline in all segments

Broad and high value patent portfolio conferring a major competitive advantage

Diverse & skilled team of scientists and industry professionals

Highly profitable financial forecast: 30 forthcoming product launches

Two biostimulant products close to market

Our Approach

Applied Nature

Inspired by

Over millions of years, plants have evolved close relationships with the microorganisms in their environment. These relationships can be highly beneficial to plants and improve health and growth. Targeted application of microorganisms that engage in these beneficial relationships can boost the fitness of crops in a natural way.


Sustainable farming
for healthy food

Microorganisms can support plants in different ways, which is reflected in Aphea.Bio's product development strategy. We focus on microbial strains that improve plant nutrient uptake (biostimulants) and strains that protect against disease (biocontrol). Our mission is to provide farmers with innovative and sustainable solutions to reduce fertilizer and pesticide use.


Biology meets

Unravelling complex interactions and identifying beneficial microbial strains requires solid scientific insights. To this end Aphea.Bio has developed an innovative R&D platform bundling different technologies in bio-informatics and microbiome mapping, state-of-the-art microorganism culturing, high-throughput crop phenotyping and data analysis.

Technology Platform

Aphea.Bio is in a unique position to deliver novel and powerful solutions to the market because of its innovative research and development platform. The R&D platform bundles several unique technologies which make up a high-throughput pipeline for discovery of new biocontrol and biostimulant products for wheat and maize.

The Team

Isabel Vercauteren

CEO and co-founder

Inge Van Daele

Portfolio & ESG

Steven Vandenabeele

CTO and co-founder

Manuele Ricci


Benoit Lixon

Business Development

Geert Bossuyt


Charlotte Klank

Reg. Affairs & Supply Chain

Discover our story

Our Investors